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Abstract
Maturation of dendritic cells (DC) is characterized by expression of CD83, a surface protein that appears to be necessary for
the effective activation of naı ¨ve T-cells and T-helper cells by DC. Lately it was shown that CD83 expression is regulated on
the posttranscriptional level by interaction of the shuttle protein HuR with a novel posttranscriptional regulatory RNA
element (PRE), which is located in the coding region of the CD83 transcript. Interestingly, this interaction commits the CD83
mRNA to efficient nuclear export via the CRM1 pathway. To date, however, the structural basis of this interaction, which
potentially involves three distinct RNA recognition motifs (RRM1–3) in HuR and a complex three-pronged RNA stem-loop
element in CD83 mRNA, has not been investigated in detail. In the present work we analyzed this interaction in vitro and in
vivo using various HuR- and CD83 mRNA mutants. We are able to demonstrate that both, RRM1 and RRM2 are crucial for
binding, whereas RRM3 as well as the HuR hinge region contributed only marginally to this protein:RNA interaction.
Furthermore, mutation of uridine rich patches within the PRE did not disturb HuR:CD83 mRNA complex formation while, in
contrast, the deletion of specific PRE subfragments from the CD83 mRNA prevented HuR binding in vitro and in vivo.
Interestingly, the observed inhibition of HuR binding to CD83 mRNA does not lead to a nuclear trapping of the transcript
but rather redirected this transcript from the CRM1- towards the NXF1/TAP-specific nuclear export pathway. Thus, the
presence of a functional PRE permits nucleocytoplasmic trafficking of the CD83 transcript via the CRM1 pathway.
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Introduction
Dendritic cells (DC) are the most potent antigen presenting cells
(APC) of the immune system. Fully activated DC are able to
induce T-cell mediated immunity and have the capacity to activate
even naı ¨ve CD4
+ or CD8
+ T-cells [1,2]. Therefore, DC are
termed ‘‘nature’s adjuvant’’. Immature DC are able to take up and
process antigens, followed by migration of the cells to the
secondary lymphoid organs, where they mature. During this
process a modulation of several expression profiles (chemokines
and chemokine receptors), as well as up-regulation of several
cytokines, costimulatory molecules and adhesion molecules occurs,
that collectively promote DC:T cell interaction and subsequently
T-cell activation (reviewed in [3–5]).
Surface expression of CD83 protein serves as a marker for
immune-competent mature DC [6,7]. Although the exact function
of CD83 remains to be investigated, various studies provided
evidence that membrane-bound and soluble CD83 are important
regulators of the immune system, for example affecting lympho-
cyte maturation as well as DC-mediated T-cell stimulation
(reviewed in [7–10]).
Since membrane-bound CD83 is strongly upregulated during
DC maturation and activation, it became of particular interest to
investigate the regulation of CD83 expression in detail on both,
the transcriptional and the posttranscriptional level [11,12].
Interestingly, the latter investigation provided initial evidence that
the transcript encoding CD83 is, in DC, exported from the
nucleus via an uncommon route [12].
In metazoans, the vast majority of mRNAs are transported from
the nuclear site of transcription to the cytoplasm, the site of protein
synthesis, via the NXF1/TAP pathway (for reviews on nuclear
mRNA export see [13,14]). However, it has also been shown that
the nucleocytoplasmic transport of a small subset of cellular
transcripts, including the CD83 mRNA, is mediated by the
unrelated CRM1 pathway [15]. CRM1 is the major nuclear
export receptor that interacts with nuclear export signals (NESs)
and mediates transport of a large variety of cellular proteins from
the nucleus to the cytoplasm [16,17]. A detailed analysis of the
CD83 transcript revealed the presence of a highly-structured cis-
active RNA element in the coding region, termed the posttran-
scriptional regulatory element (PRE), which is directly recognized
by the cellular RNA-binding shuttle protein HuR [18].
The human HuR protein is a ubiquitously expressed member of
a family of RNA-binding proteins that is related to the Drosophila
ELAV (embryonic lethal abnormal vision) protein [19–22]. HuR
appears to be a multifunctional regulator that is involved in the
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affecting their stability, transport or translation (reviewed in [23–
25]. Binding of HuR to transcripts bearing U- and AU-rich RNA
elements (AREs) [26], which are commonly located in their 39-
untranslated region (UTR), results in significant stabilization of
these otherwise highly labile mRNAs (reviewed in [24,27]. In
contrast, binding of HuR to the coding sequence PRE of CD83
mRNA does not affect the stability of this transcript, but instead
induces its efficient CRM1-mediated cytoplasmic accumulation
[18]. Since HuR is unable to directly interact with CRM1 [28],
both, PRE-bound HuR and CRM1 have to be connected by an
adaptor molecule. In fact, functional analysis of the known HuR
protein ligands pp32 (ANP32A) and APRIL (ANP32B) [28]
revealed that the latter links HuR and CRM1 during nucleocy-
toplasmic translocation of CD83 mRNA in a highly specific
manner [29,30].
Inthepresent workwehavecharacterized theHuR:CD83mRNA
interaction by in vitro binding assays using various HuR and PRE
RNA mutant constructs. Furthermore, we analyzed the contribution
of the CRM1- and the NXF1/TAP-specific nuclear export pathway
to the nucleocytoplasmic transport of selected CD83 mRNA mutants
(i.e. PRE mutants) in transfected cell cultures.
Results
HuR binds specifically the PRE in CD83 mRNA
To assess the binding of HuR to CD83 mRNA, RNA gel
retardation experiments were performed. For this, HuR was
expressed and purified in the context of a fusion to GST
(glutathione S-transferase) and then analyzed in combination with
in vitro transcribed radiolabelled CD83-specific RNA probes. In
agreement with data presented in a previous study [18], addition
of increasing amounts of GST-HuR to the CD83 wildtype (wt)
coding region probe (nt 1–615) [31] resulted in the appearance of
an RNA:protein complex with slower mobility upon nondenatur-
ing gel electrophoresis (Figure 1A, lane 3–7), compared with the
migration of the uncomplexed RNA probe (Figure 1A, lane 1) or
when GST alone was added to the binding reaction (Figure 1A,
lane 2). In contrast, complex formation was not observed, even at
high HuR concentrations, when the CD83 wt sequence was
substituted by a corresponding RNA probe in which the PRE (nt
466–615) was deleted (CD83DPRE; see Figure 1A, lane 8–14).
Thus, the PRE constitutes the only HuR target structure in the
CD83 coding sequence.
Next, we investigated the specificity of this protein:RNA
interaction. Therefore, RNA competition experiments were
performed in which increasing amounts of unlabelled and highly
structured heterologous RNAs were added to the CD83 PRE:-
HuR binding reaction. As shown in Figure 1B, addition of the
unrelated Rev Response Element (RRE) RNA, which constitutes
the high-affinity binding site of the RNA-binding retroviral Rev
transactivator in incompletely-spliced or unspliced HIV-1 tran-
scripts [32,33], did not negatively affect PRE:HuR complex
formation (lane 5–9). In sharp contrast, however, strong binding
competition, as indicated by diminished PRE-specific signals, was
observed when the TNFa ARE, an established and prototypic
HuR target sequence [34,35], was used in these experiments
(Figure 1B, lane 14–18). In sum these data indicated specific
interaction of HuR with CD83 mRNA.
RRM1 and RRM2 of HuR are necessary for CD83 mRNA
binding
HuR belongs to a family of ELAV-like proteins that are
characterized by a modular structure composed of several
functionally distinct domains [19,22]. In particular, the interaction
of HuR with RNA is mediated via three independent copies of the
classical RNA recognition motif (RRM1–3), which is one of the
most abundant protein domains in eukaryotes [36,37]. While
RRM1 and RRM2 are arranged in tandem, RRM2 and RRM3
are separated by a less conserved flexible hinge region (Figure 2A),
which has been reported to contain a sequence required for
nucleocytoplasmic shuttling of HuR [38].
To investigate which region of HuR is involved in CD83
mRNA binding, recombinant GST and several GST-HuR fusion
proteins were prepared (Figure 2, A and B) and subjected to CD83
RNA-specific gel retardation assay as before (Figure 2C). Inspec-
tion of the obtained data revealed that a HuR mutant comprising
RRM1, RRM2 and the hinge region clearly binds to the CD83
PRE sequence but, when compared to the full-length protein, with
apparently reduced affinity (Figure 2C, lane 2 and 3). In contrast,
RRM1 or RRM2 by itself failed to bind to the CD83 input RNA
probe (Figure 2C, lane 4 and 5), a result that strongly resembled
the data obtained when GST alone was used in a control
experiment (Figure 2C, lane 1). In the same manner, neither
RRM3 nor hinge domain-containing variants of RRM2 or RRM3
were able to interact with CD83 mRNA (Figure 2C, lane 6–8). As
expected, also the GST fusion protein containing the isolated HuR
hinge region failed to interact with the RNA probe in these
experiments (Figure 2C, lane 9). These experiments therefore
suggest that both, RRM1 and RRM2 are necessary for CD83
mRNA binding, whereas the more carboxyterminal regions of
HuR seem not to be directly involved in PRE RNA target
recognition.
All potential CD83 PRE subloops contribute to HuR
binding
Inspection of the PRE revealed, that this CD83 mRNA-derived
sequence does not contain a classical ARE [18,26]. However, two
uridine-rich patches that are part of the PRE (UUUUUCU at nt
522–28 and UUUUCU at nt 549–54) could potentially serve as an
HuR binding site (see [39] and references therein). To test this
possibility, several CD83 PRE mutants were constructed in which
these potential binding sites, termed URE1 and URE2 (uridine-rich
elements 1 and 2; CUUCUCA and AUUCCU, respectively), were
either individually or collectively altered by wobble mutagenesis (i.e.
without affecting the coding capacity of the respective sequence).
Gel retardation experiments using these constructs revealed that
neitherthemutationofasingle URE(Figure 3A,lane7–10and lane
12–15), nor the alteration of both sequence elements (Figure 3A,
lane 17–20) significantly affected the binding of HuR to the PRE.
These data suggested that binding of HuR to CD83 mRNA
represents not a simple sequence-specific association.
The CD83 PRE is a structured RNA element that potentially
forms a stem loop with three apical substructures [18]. Hence, we
next constructed a series of CD83 PRE mutants in which these
apical substructures, termed subloop (SubL) 1 to 3, were
individually deleted. The in vitro analysis of the respective RNAs
by HuR-specific gel retardation assay indicated that deletion of
SubL1 (DSubL1), corresponding to nucleotides (nt) 498–537 in the
CD83 mRNA coding region [18,31], abolished the binding of
HuR to PRE RNA (Figure 3B, lane 2–4 versus lane 6–8).
However, when SubL2 (nt 543–555) or SubL3 (nt 561–594) was
deleted from the PRE, some residual binding was still observed
(Figure 3B, lane 10–12 and 14–16, respectively). These in vitro
data suggested that the entire CD83 PRE is necessary for efficient
HuR binding.
To detect an association of HuR with CD83 mRNA in vivo, we
next performed an immuno-PCR experiment. COS7 cells were
Dissection of the HuR:CD83 mRNA RNP Complex
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e23290transiently transfected with expression vectors encoding either for
human CD83 cDNA flanked by the entire homologous 59- and 39-
untranslated region (UTR) or variants thereof, encoding PRE
SubL-deletions. At day two posttransfection, endogenous HuR
protein was covalently crosslinked to the CD83 mRNA by addition
of formaldehyde to the respective cell culture. Afterwards, HuR was
immunoprecipitated using a polyclonal HuR antiserum, bound
CD83 mRNA was reverse transcribed and the presence of
coimmunoprecipitated CD83 mRNA was determined by specific
PCR. By using this experimental set-up, it has been already
previously shown that no specific binding could be observed when
the CD83 message lacked all three PRE SubL elements [18]. In
agreement with this data and shown in Figure 3C, the endogenous
HuR protein strongly interacted with the full-length CD83
transcript (lane 2). In contrast, however, deletion of the individual
SubL structures resulted in an intermediate HuR-binding pheno-
type, which was reflected by the diminished rescue of CD83-specific
sequences (lane 3–5).Controlexperiments in whichrabbitIgG (lane
1) was used for immunoprecipitation or in which the PCR template
was omitted (lane 6) resulted in the expected negative phenotypes.
Overall, these in vivo experiments not perfectly mirrored, but
resembled to a significant extent the data obtained beforeby in vitro
gel retardation assay. This indicates that the entire PRE contributes
to HuR binding, although the data may also point to a more
complex binding scenario which has not yet been fully understood.
The PRE directs CD83 mRNA into the CRM1 nuclear
export pathway
It has been previously shown that CD83 expression and the
nuclear export of CD83 mRNA is sensitive to leptomycin B (LMB)
Figure 1. HuR binds in a specific manner to the CD83 PRE RNA region. A. Increasing amounts of bacterial expressed GST-HuR protein was
incubated either with the radiolabelled CD83 mRNA wildtype (wt) coding sequence (CD83wt; lane 1–7) or the respective probe lacking the HuR
target sequence PRE (CD83DPRE; lane 8–14). Complex formation was visualized by gel retardation assay and autoradiography. Lane 1: CD83wt RNA
alone; lane 2: GST negative control; lane 3–7 increasing amounts of GST-HuR (0.095–0.475 mM); lane 8: CD83DPRE alone; lane 9: GST negative control;
lane 10–14: increasing amounts of GST-HuR (0.095–0.475 mM). B. Analysis of PRE binding specificity by competition experiments. GST-HuR protein
(lane 2–4 and lane 11–13: 0.119 mM, 0.238 mM, 0.475 mM, respectively; lane 5–9 and 14–18: 0.475 mM, respectively) or GST (1 mM) for negative control
(lane 1 and 10) was incubated together with radiolabelled CD83wt PRE mRNA and analyzed as before. Increasing amounts (1–5 fold excess over
CD83wt PRE mRNA) of either unlabelled HIV-1 RRE RNA (lane 5–9) or unlabelled TNFa ARE RNA (lane 14–18) were added to individual binding
reactions.
doi:10.1371/journal.pone.0023290.g001
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modifies an essential cysteine residue in CRM1 and thereby
inactivates selectively this nuclear export receptor [41,42]. We
therefore wanted to investigate the influence of the PRE
subdomains with respect to the cellular mRNA nuclear export
pathways. Therefore, COS7 cells were transfected with the CD83
expression vector as before. Two days after transfection, the cell
culture was exposed to 10 nM LMB for 8 hours. Subsequently,
total, cytoplasmic and nuclear RNA was isolated and reverse-
transcribed into cDNA for PCR-mediated detection of CD83 and
GAPDH (control) transcripts. Confirming previous studies [18,40],
the cytoplasmic accumulation of CD83 mRNA was significantly
impaired when CRM1 activity was blocked by LMB in this
experiment (Figure 4A, lane 3 and 4), whereas in the total and the
nuclear RNA fraction no reduction of CD83 mRNA levels was
observed (Figure 4A, lane 1 and2 and lane 5 and 6,respectively).By
following this experimental design we next analyzed a CD83
transcript in which PRE SubL1–3 was deleted (DSubL1–3). In
sharp contrast to the results described above, LMB did now not
affect the cytoplasmic accumulation of this CD83 mRNA,
suggesting that CRM1 was not operational in the nuclear export
of PRE SubL1–3-deficient transcripts (Figure 4A, lane 7–12). To
further substantiate this observation, we subjected the respective
RNAs also to quantitative real-time PCR. This confirmed the
notion, that the PREin CD83 mRNApermitsnuclear exportof this
transcript via the CRM1 pathway (Figure 4B).
Since the PRE-deficient CD83 transcript was apparently
exported from the nucleus in a CRM1-independent fashion
(Figure 4A and B), we now wanted to investigate the potential
involvement of an alternative, CRM1-unrelated export route in
this transport process. Clearly, the export receptor NXF1/TAP,
which is known to transport the bulk of cellular transcripts out of
the nucleus [13,14], is a prime candidate to specify such a
pathway. Unfortunately, to date no small-molecular weight
inhibitor that specifically targets NXF1/TAP exists. However,
the ‘‘simple’’ D-type retrovirus Mason-Pfizer monkey virus
(MPMV) exploits the NXF1/TAP-pathway by directly binding
NXF1/TAP via a structured RNA sequence element, termed the
constitutive transport element (CTE) [43]. Therefore, intracellular
overexpression of multiple CTE NXF1/TAP target sites provides
a means to inhibit NXF1/TAP activity. As expected and shown in
Figure 4C, overexpression of four tandem repeats of the MPMV
CTE (46CTE) [44] did indeed negatively affect the nuclear export
of CD83 PREDSubL1–3 mRNA (lane 3 and 4), reflecting a
functionally compromised NXF1/TAP pathway. Again, this result
was quantified by real-time PCR (Figure 4D).
Obviously, the PRE in CD83 mRNA enables nucleocytoplas-
mic translocation of this mRNA via the CRM1-pathway, whereas
deletion of the PRE makes this RNA subject to regulation by the
NXF1/TAP export receptor and its associated factors.
Discussion
The CD83 protein serves as surface marker for fully matured
DC [45,46]. Although its exact function is still unknown [47],
various independent findings suggest that this protein plays a
pivotal role in immune regulation and may therefore hold great
potential for therapeutic application [6–9].
Figure 2. RRM1 and RRM2 of HuR are necessary for efficient CD83 mRNA recognition. A. Schematic diagram of the domain structure of
HuR. The positions of the three RNA recognition motifs (RRM1–3) and the hinge region (H) in the human 326 amino acid (aa) HuR protein are
indicated. Recombinant proteins (indicated by probe #) which were subsequently analyzed for CD83 PRE binding are depicted. Probe numbers
correspond to gel lanes in panel B and C. B. Coomassie-stained SDS-PAGE of the recombinantly expressed and purified proteins (indicated by
arrowheads). M, marker proteins. C. Radiolabelled CD83wt PRE coding sequence RNA was incubated either with GST (negative control) or with
various HuR-derived GST-fusion proteins. Lane 1: GST; lane 2: full-length HuR; lane 3: HuR aa 1–244 (RRM1-RRM2-H); lane 4: HuR aa 27–93 (RRM1); lane
5: HuR aa 108–174 (RRM2); lane 6: HuR aa 246–317 (RRM3); lane 7: HuR aa 103–244 (RRM2-H); lane 8: HuR aa 190–328 (H-RRM3); HuR aa 175–245 (H).
CD83 PRE RNA:protein interaction was analyzed by gel retardation assay as before.
doi:10.1371/journal.pone.0023290.g002
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the level of nucleocytoplasmic transport [15,18]. Generally, the
translocation of the vast bulk of cellular mRNAs across the nuclear
envelope is mediated by the nuclear export factor NXF1/TAP
[13,14]. In comparison, nuclear mRNA export mediated by the
importin b-related export receptor CRM1 appears to be a rather
rare event, since CRM1 usually mediates the transit of noncoding
rRNA and U snRNA, ribosomal subunits and numerous proteins
through the nuclear pore complex [17,48]. However, CRM1 is
exploited by HIV-1 to export the viral unspliced and incompletely-
spliced mRNAs [49]. Interestingly, by employing a systematic
screen in human cells, several cellular mRNAs were identified that
are also exported from the nucleus to the cytoplasm via the CRM1
pathway [15]. These transcripts are expressed upon cellular
activation or differentiation and include the transcript encoding
the CD83 molecule [15,18]. Association of CRM1 with the CD83
transcript requires specific adaptor molecules. In particular, the
RNA-binding cellular shuttle protein HuR has been identified to
directly bind with high-affinity the cis-active CD83 PRE mRNA
sequence [18]. Subsequently, CRM1 is recruited to the nuclear
CD83 mRNA:HuR ribonucleoprotein (RNP) complex by APRIL
(ANP32B) [29], a family member of a group of leucine-rich acidic
nuclear phosphoproteins that is able to bind at the same time to
both, HuR and CRM1 [28]. Thus, initial recognition of the CD83
transcript by HuR is pivotal to all consecutive processes that
eventually result in CRM1-mediated nuclear export of HuR-
bound CD83 transcripts.
The RNA-binding HuR protein has been shown to efficiently
shuttle between the nuclear and cytoplasmic compartment
[50,51]. It appears that both, its RNA-binding and nucleocyto-
plasmic shuttling activity can be attributed to distinct domains of
HuR [19,22,38]. Upon nuclear import, HuR binds via its RRMs
to specific mRNAs. These mostly belong to the class of short-lived
early response gene (ERG) mRNAs that encode functionally
important proteins such as protooncoproteins, cytokines and
lymphokines. Their intrinsic instability depends on the presence of
ARE sequences [26], which enhance deadenylation rates as well as
mRNA degradation [52–54]. Importantly, upon binding to HuR
these ARE-containing transcripts are profoundly stabilized
[50,52,52].
It has been demonstrated that ARE recognition by HuR is
mediated by the protein’s two tandemly arranged RRMs (RRM1
and RRM2) [39,55], while the carboxyterminal RRM3 appears to
bind to the poly(A) tail of the respective ERG mRNA [56].
Deletion of RRM3 in the closely related HuD protein has been
shown to only moderately reduce its ARE binding affinity [57].
Moreover, it has also been reported that the RRM3 in HuR does
not contribute to high affinity binding, but is rather required for
the cooperative assembly of HuR oligomers on RNA [58]. These
phenotypes closely resemble the HuR binding-data raised in the
present study, indicating that RRM1 and RRM2 are essential for
efficient recognition of the CD83 PRE RNA sequence and that
RRM3 is not directly involved in PRE interaction (Figure 2C).
However, binding of HuR to the ARE [55], as well as to the PRE
(Figure 2C), occurred most efficiently when the RRM3 was
present, despite the fact that the in vitro analyzed RNAs were
devoid of a poly(A) tail, as mentioned before, constituting an
established RRM3 binding substrate [56]. Thus, in case of both
HuR target sequences, the ARE and the PRE, highly efficient
protein:RNA complex formation appears to require the presence
of all three RRMs. This may suggest that the tandemly arranged
RRM1 and RRM2 primarily provide binding specificity to HuR,
while RRM3 further stabilizes this binding event by secondary
interactions with the respective RNA target.
The RNA binding and immuno-PCR experiments performed in
the present study demonstrated that all PRE substructures are
required for optimal HuR binding (Figure 3). Furthermore, these
data confirmed in an independent approach the previous notion
that the CD83 PRE:HuR interaction is not solely based on the
association of HuR with uridine-rich patches, but rather depends
on HuR’s recognition of the complete PRE structure [18].
Interestingly, deletion of the PRE from the CD83 mRNA directed
this transcript away from the CRM1- into the NXF1/TAP-specific
nuclear export pathway (Figure 4). Thus, the cis-active PRE
secures nucleocytoplasmic CD83 mRNA translocation via CRM1.
One may therefore speculate that this specific export route might
provide a significant advantage with respect to efficient protein
synthesis when compared to the more general pathway involving
NXF1/TAP, particularly under conditions of cellular activation.
In fact, this notion is increasingly supported by studies identifying
specific cellular transcripts that are translocated from the nucleus
to the cytoplasm by CRM1. These include the transcript coding
for interferon-a1, c-Fos, Cyclin D1, cyclooxygenase-2, HLA-A
and, most notably, HuR itself [28,59–64]. An additional example
is represented by the k-opioid receptor (KOR) mRNA that also
utilizes HuR and CRM1 to form a nuclear export complex [65],
thereby resembling the mechanism involved in the nuclear export
of CD83 mRNA. Moreover, in analogy with the CD83 PRE a cis-
active element has been recently identified in the coding region of
interferon-a1 mRNA that mediates, although in an HuR-
independent manner, the aforementioned CRM1-dependent
nuclear export of this message [66]. Taken together, these data
suggest that utilization of CRM1, either via HuR and its ligands
(e.g. APRIL/ANP32B), or via HuR-unrelated adaptors, is
frequently a common denominator of mRNAs that are induced
during cell activation or differentiation. Conceivably, this
mechanism ensures the timely and efficient nuclear export, and
thereby protein expression, of these transcripts.
Materials and Methods
Molecular Clones
The plasmids p3CD83-CDS (CD83 coding sequence [CDS]
nucleotides [nt] 1–615; [31], p3CD83-PRE (nt 466–615),
Figure 3. Deletion of individual CD83 PRE substructures impairs binding to HuR. A. GST alone (negative control, 2.2 mM, lane 1, 6, 11, 16)
or increasing amounts of recombinant GST-HuR (0.19 mM, 0.38 mM, 0.57 mM, 0.95 mM) were incubated with radiolabelled CD83wt PRE RNA or several
combinations of uridine-rich element (URE) mutants as indicated at the top of the panels. Formation of protein-RNA interaction (indicated by
arrowhead) was subsequently detected by gel retardation analysis. B. GST alone (negative control; 2.2 mM, lane 1, 5, 9, 13) or increasing amounts of
recombinant GST-HuR (0.237 mM, 0.475 mM, 0.95 mM; lanes 2–4, 6–8, 10–12, 14–16, respectively) were incubated together with radiolabelled full-
length CD83wt PRE RNA or various PRE subloop (SubL) deletions (depicted at the top of the panels). Complex formation (indicated by arrowhead)
was subsequently visualized by gel retardation assay as before. C. COS7 cells were transfected with expression vectors encoding for human CD83
cDNA flanked by the entire homologous 59- and 39-UTR (lane 1 and 2) or derivatives thereof (lane 3: DSubL1; lane 4: DSubL2; lane 5: DSubL3). Cellular
lysates were subjected to immuno-PCR using anti-HuR antiserum (lane 2–5) or rabbit IgG for negative control (lane 1). CD83-specific RNA was
detected by PCR followed by gel electrophoresis. A mock reaction without template served as additional negative control (nc; lane 6). This
experiment has been reproduced at least three times with the same results.
doi:10.1371/journal.pone.0023290.g003
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full length HuR) and p3UTR-CD83 were published previously
[18]. The vector p46CTE expresses 4 tandem copies of the
MPMV CTE [44] which were ligated between EcoRI and XhoI
sites of pcDNA3 (Invitrogen). For in vitro transcription, the
plasmids p3CD83CDSDPRE (CD83 CDS deletion nt position
466–615), p3CD83PREDSubL1 (CD83 CDS deletion nt position
498–537), p3CD83PREDSubL2 (CD83 CDS deletion nt position
543–555) and p3CD83PREDSubL3 (CD83 CDS deletion nt
position 561–594), p3CD83PREDURE1 (nt position 522–528,
GAT TTT TCTRGAC TTC TCA), p3CD83PREDURE2 (nt
position 549–554, GCT TTT CTCRGCA TTC CTA) and
p3CD83PREDURE1+2 (nt position 522–528, GAT TTT
TCTRGAC TTC TCA; nt position 549–554, GCT TTT
CTCRGCA TTC CTA), were constructed using PCR technol-
ogy. The respective CD83 CDS-derived fragments were ligated
between the HindIII and EcoRI sites of the pcDNA3 vector.
Likewise, the eukaryotic expression vectors p3UTR-
CD83DSubL1 (CD83 CDS nt 498–537 deletion), p3UTR-
CD83DSubL2 (CD83 CDS nt 543–555 deletion), p3UTR-
CD83DSubL3 (CD83 CDS nt 561–594 deletion), p3UTR-
CD83DSubL1–3 (CD83 CDS nt 498–594 deletion), were
constructed by ligating the respective PCR-generated CD83
CDS-derived fragments between the HindIII and Asp718 sites
of the p3UTR-CD83 vector [18].
The expression plasmids for purification of the GST-proteins,
pGex-HuR1–244 (aa 1–244; RRM1 + RRM2 + hinge region),
pGex-HuR27–93 (aa 27–93; RRM1), pGex-HuR108–174 (aa
108–174; RRM2), pGex-HuR246–317 (aa 246–317; RRM3),
pGex-HuR103–244 (aa 103–244; RRM2 + hinge region), pGex-
Figure 4. CRM1-mediated nuclear export of CD83 mRNA PRE. A. COS7 cells were transiently transfected either with an expression vector
encoding for human CD83 cDNA flanked by the homologous 59- and 39-UTR (wt; lane 1–6) or with a related vector in which essential PRE sequences
were deleted (PREDSubL1–3; lane 7–12). At day two posttransfection cultures were exposed to 10 nM of the CRM1 inhibitor LMB or DMSO (solvent
control) for 8 hours. Total, cytoplasmic and nuclear RNA was isolated, subjected to CD83- and GAPDH-specific (negative control) PCR and analyzed by
gel electrophoresis. B. Quantitative real-time PCR of the RNA probes shown in panel A. RNA ratios +LMB/2LMB are depicted. C. Total, cytoplasmic
and nuclear RNA was isolated from cell cultures which were cotransfected with the CD83 PREDSubL1–3 expression vector and either a construct
expressing four tandem repeats of the MPMV CTE (46CTE) or the respective parental vector (negative control). For NXF1/TAP-independent control,
mitochondrial cytochrome C oxidase mRNA was detected in total and cytoplasmic RNA, while GAPDH-specific transcripts were detected in nuclear
RNA. D. Quantitative real-time PCR of the RNA probes shown in panel C. RNA ratios +/2 NXF1/TAP inactivation (+CTE/2CTE) are depicted.
doi:10.1371/journal.pone.0023290.g004
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HuR175–245 (aa 175–245; hinge region) are based on the
parental vector pGex-56-1 (Pharmacia Biotech).
Protein Purifications and RNA Gel Retardation Assays
GST fusion proteins were expressed in E. coli BL21 and purified
from crude lysates by affinity chromatography on glutathione-
Sepharose 4B (Pharmacia) as described previously [67]. RNA gel-
retardation assays were performed using in vitro-transcribed [
32P]-
labelled CD83-derived probes, MS2 competitor RNA and GST
fusion protein as previously described [68], except that RNA-
protein complexes were separated on 4% or 6% native
polyacrylamide gels.
In Vitro Transcription
Labelled and non-labelled RNA was obtained by in vitro
transcription with or without [a-
32P] UTP (Amersham Pharmacia)
using a commercial T7 RNA polymerase-based kit following the
manufacturer’s instructions (Promega).
Immuno-PCR
COS7 cells (5610
6) were transfected with 8 mg DNA of either
p3UTR-CD83, p3UTR-CD83DSubL1, p3UTR-CD83DSubL2
or p3UTR-CD83DSubL3 expression vector, respectively, using
the DEAE dextran transfection method. Two days after
transfection endogenous HuR protein was covalently cross-linked
to CD83 mRNA by adding 1% formaldehyde to the medium for
5 minutes. Afterwards, crude extracts were prepared and HuR
was immunoprecipitated with a polyclonal HuR antiserum, bound
CD83 mRNA was reverse transcribed and the presence of
coimmunoprecipitated CD83 mRNA sequences was determined
by specific PCR using DNA-oligos described below. Rabbit IgG
(instead of HuR antibodies) or water was used for PCR control.
Cell Culture and Transfections
The cell line COS7 (ATCC CRL-1651
TM) was maintained as
previously described [69]. For analysis of CD83 RNA-synthesis
and distribution 2.5610
5 COS7 cells were transfected with 250 ng
of either p3UTR-CD83 or p3UTR-CD83DSubL1–3 vector, using
DEAE-dextran and chloroquine as previously described [18].
Likewise, 1 mg of the p46CTE expression vector was cotrans-
fected with 250 ng of either the p3UTR-CD83 or p3UTR-
CD83DSubL1–3 vector, respectively.
RNA Isolation and PCR Analyses
Total cellular RNAs were isolated according to the manufac-
turer’s protocol by using TRIzol reagent (Invitrogen). For isolation
of cytoplasmic and nuclear RNAs, 2610
5 cells were lysed on ice
for 1 min using 100 ml NP40 buffer (10 mM Hepes- KOH
pH 7.8, 10 mM KCl, 20% glycerol, 1 mM DTT, 0.25% NP40).
Subsequently, the lysates were cleared by centrifugation at 4706g
for 5 min at 4uC. Cytoplasmic RNA was isolated from 80 ml of the
supernatant using TRIzol reagent. The nuclei were washed again
in 100 ml NP40 buffer to deplete residual cytoplasmic RNA.
Afterwards, the nuclear RNA was isolated by using TRIzol
reagent. DNAse treatment of the RNA samples was performed.
Selected RNA samples were reversely transcribed using the first
strand cDNA (AMV) synthesis kit for RT-PCR (Roche Molecular
Biochemicals) according to the manufacturer’s instructions.
Subsequently, RT products were assayed by PCR. For detection
of GAPDH sequences following primers were used: forward, 59-
TGAAGGTCGGAGTCAACGGATTTGGT-39; reverse, 59-
CATGTGGGCCATGAGGTCCACCAC-39. The amplification
profile involved 25 cycles of denaturation at 95uC for 1 minute,
primer annealing at 56uC for 1 minute, and primer extension at
72uC for 2 minutes. CD83 mRNAs were detected by using
following primer pairs: forward, 59 GGT GAA GGT GGC TTG
CTC CGA AG-39, and reverse, 59-GAG CCA GCA GCA GGA
CAA TCT CC-39. The amplification profile involved 25 cycles of
denaturation at 95uC for 1 minute, primer annealing at 56uC for
1 minute, and primer extension at 72uC for 1 minute. Cytocrome
C oxidase subunit II mRNAs were detected by using following
primer pairs: forward, 59 GCA AGT AGG TCT ACA AGA CG-
39, and reverse, 59-GTA GTC GGT GTA CTC GTA GG-39.
The amplification profile involved 25 cycles of denaturation at
95uC for 1 minute, primer annealing at 56uC for 1 minute, and
primer extension at 72uC for 1 minute. Real time PCR was
performed as described previously [18].
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